8-18084687-CAGCAAAG-C
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 10P and 1B. PVS1PM2BS1_Supporting
The NM_004315.6(ASAH1):c.108_114delCTTTGCT(p.Ser36fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00027 in 1,613,676 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.0014 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00015 ( 0 hom. )
Consequence
ASAH1
NM_004315.6 frameshift
NM_004315.6 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.545
Genes affected
ASAH1 (HGNC:735): (N-acylsphingosine amidohydrolase 1) This gene encodes a member of the acid ceramidase family of proteins. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. Processing of this preproprotein generates alpha and beta subunits that heterodimerize to form the mature lysosomal enzyme, which catalyzes the degradation of ceramide into sphingosine and free fatty acid. This enzyme is overexpressed in multiple human cancers and may play a role in cancer progression. Mutations in this gene are associated with the lysosomal storage disorder, Farber lipogranulomatosis, and a neuromuscular disorder, spinal muscular atrophy with progressive myoclonic epilepsy. [provided by RefSeq, Oct 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00141 (215/152332) while in subpopulation AFR AF= 0.00491 (204/41580). AF 95% confidence interval is 0.00435. There are 1 homozygotes in gnomad4. There are 108 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASAH1 | NM_004315.6 | c.108_114delCTTTGCT | p.Ser36fs | frameshift_variant | 1/14 | NP_004306.3 | ||
ASAH1 | NM_001127505.3 | c.108_114delCTTTGCT | p.Ser36fs | frameshift_variant | 1/14 | NP_001120977.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASAH1 | ENST00000381733.9 | c.108_114delCTTTGCT | p.Ser36fs | frameshift_variant | 1/14 | 1 | ENSP00000371152.4 | |||
ASAH1 | ENST00000314146.10 | c.108_114delCTTTGCT | p.Ser36fs | frameshift_variant | 1/14 | 1 | ENSP00000326970.10 | |||
ASAH1 | ENST00000637244.1 | n.108_114delCTTTGCT | non_coding_transcript_exon_variant | 1/14 | 1 | ENSP00000490188.1 |
Frequencies
GnomAD3 genomes AF: 0.00141 AC: 214AN: 152214Hom.: 1 Cov.: 33
GnomAD3 genomes
AF:
AC:
214
AN:
152214
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000341 AC: 85AN: 249026Hom.: 0 AF XY: 0.000297 AC XY: 40AN XY: 134704
GnomAD3 exomes
AF:
AC:
85
AN:
249026
Hom.:
AF XY:
AC XY:
40
AN XY:
134704
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000151 AC: 220AN: 1461344Hom.: 0 AF XY: 0.000127 AC XY: 92AN XY: 726888
GnomAD4 exome
AF:
AC:
220
AN:
1461344
Hom.:
AF XY:
AC XY:
92
AN XY:
726888
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00141 AC: 215AN: 152332Hom.: 1 Cov.: 33 AF XY: 0.00145 AC XY: 108AN XY: 74482
GnomAD4 genome
AF:
AC:
215
AN:
152332
Hom.:
Cov.:
33
AF XY:
AC XY:
108
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2022 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Oct 24, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at